相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Evaluation of High-Sensitivity Assays for Cardiac Troponin
David A. Morrow et al.
CLINICAL CHEMISTRY (2009)
Pentraxin 3, a new marker for vascular inflammation, predicts adverse clinical outcomes in patients with heart failure
Satoshi Suzuki et al.
AMERICAN HEART JOURNAL (2008)
Key issues in the developing synergism between cardiovascular imaging and biomarkers
Allan S. Jaffe
CLINICAL CHEMISTRY (2008)
Cardiovascular biomarkers: increasing impact of laboratory medicine in cardiology practice
Simona Vittorini et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2008)
Distribution of plasma cardiac troponin I values in healthy subjects: pathophysiological considerations
Aldo Clerico et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2008)
New cardiovascular risk factors exist, but are they clinically useful?
Thomas J. Wang
EUROPEAN HEART JOURNAL (2008)
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008 The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM)
Kenneth Dickstein et al.
EUROPEAN JOURNAL OF HEART FAILURE (2008)
Characteristics of the Novel Interleukin Family Biomarker ST2 in Patients With Acute Heart Failure
Shafiq U. Rehman et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)
Biomarkers in heart failure
Eugene Braunwald
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Meta-analysis of B type natriuretic peptide and N-terminal pro B natriuretic peptide in the diagnosis of clinical heart failure and population screening for left ventricular systolic dysfunction
B. Ewald et al.
INTERNAL MEDICINE JOURNAL (2008)
Observed differences in diagnostic test accuracy between patient subgroups: Is it real or due to reference standard misclassification?
Corne Biesheuvel et al.
CLINICAL CHEMISTRY (2007)
Prognostic utility of growth differentiation factor-15 in patients with chronic heart failure
Tibor Kempf et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2007)
Prognostic value of very low plasma concentrations of troponin T in patients with stable chronic heart failure
Roberto Latini et al.
CIRCULATION (2007)
Comparison of brain natriuretic peptide (BNP) and amino-terminal ProBNP for early diagnosis of heart failure
Michele Emdin et al.
CLINICAL CHEMISTRY (2007)
The human disease network
Kwang-Il Goh et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Comparison of the diagnostic accuracy of brain natriuretic peptide (BNP) and the N-terminal part of the propeptide of BNP immunoassays in chronic and acute heart failure: A systematic review
Aldo Clerico et al.
CLINICAL CHEMISTRY (2007)
Comparative evaluation of B-type natriuretic peptide, mid-regional pro-A-type natriuretic peptide, mid-regional pro-adrenomedullin, and copeptin to predict 1-year mortality in patients with acute destabilized heart failure
Alfons Gegenhuber et al.
JOURNAL OF CARDIAC FAILURE (2007)
Prevention of high-dose chemotherapy-induced cardiotoxicity in high-risk patients by angiotensin-converting enzyme inhibition
Daniela Cardinale et al.
CIRCULATION (2006)
Novel and potential future biomarkers for assessment of the severity and prognosis of chronic heart failure - A clinical review
David R. Buvat de Virginy
HEART FAILURE REVIEWS (2006)
The genetic bases of cardiomyopathies
Pascale Richard et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2006)
Redefining heart failure: The utility of genomics
Mark P. Donahue et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2006)
Utility of amino-terminal pro-brain natriuretic peptide, galectin-3, and apelin for the evaluation of patients with acute heart failure
Roland R. van Kimmenade et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2006)
Biomarkers of cardiovascular disease - Molecular basis and practical considerations
Ramachandran S. Vasan
CIRCULATION (2006)
Prevalence and determinants of troponin T elevation in the general population
TW Wallace et al.
CIRCULATION (2006)
Cardiac endocrine function is an essential component of the homeostatic regulation network: physiological and clinical implications
A Clerico et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2006)
N-terminal pro-B-type natriuretic peptide after high-dose chemotherapy: A marker predictive of cardiac dysfunction?
MT Sandri et al.
CLINICAL CHEMISTRY (2005)
Detection of cardiac sarcoidosis using cardiac markers and myocardial integrated backscatter
H Yasutake et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2005)
Guidelines for the diagnosis and treatment of chronic heart failure:: executive summary (update 2005)
K Swedberg et al.
EUROPEAN HEART JOURNAL (2005)
Novel markers for heart failure diagnosis and prognosis
DS Lee et al.
CURRENT OPINION IN CARDIOLOGY (2005)
How well does B-type natriuretic peptide predict death and cardiac events in patients with heart failure: systematic review
JA Doust et al.
BRITISH MEDICAL JOURNAL (2005)
Prognostication of survival using cardiac troponins and N-terminal pro-brain natriuretic peptide in patients with primary systemic amyloidosis undergoing peripheral blood stem cell transplantation
A Dispenzieri et al.
BLOOD (2004)
Prognostic value of troponin I in cardiac risk stratification of cancer patients undergoing high-dose chemotherapy
D Cardinale et al.
CIRCULATION (2004)
Diagnostic accuracy and prognostic relevance of the measurement of cardiac natriuretic peptides: A review
A Clerico et al.
CLINICAL CHEMISTRY (2004)
A systematic review of the diagnostic accuracy of natriuretic peptides for heart failure
JA Doust et al.
ARCHIVES OF INTERNAL MEDICINE (2004)
Serum N-terminal pro-brain natriuretic peptide is a sensitive marker of myocardial dysfunction in AL amyloidosis
G Palladini et al.
CIRCULATION (2003)
分享论文
